Pages that link to "Q35941237"
Jump to navigation
Jump to search
The following pages link to Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations (Q35941237):
Displaying 50 items.
- Clinical perspectives on echinocandin resistance among Candida species (Q28082538) (← links)
- Echinocandin resistance: an emerging clinical problem? (Q28544739) (← links)
- Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011. (Q30826889) (← links)
- Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates. (Q33622743) (← links)
- Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment. (Q33798606) (← links)
- Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance (Q34058099) (← links)
- Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study. (Q35880078) (← links)
- Echinocandin Resistance in Candida (Q36276186) (← links)
- Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection (Q36290758) (← links)
- Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations (Q36364100) (← links)
- Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations (Q36856930) (← links)
- Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species (Q36933366) (← links)
- Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr (Q37036246) (← links)
- Candida glabrata: a review of its features and resistance (Q38163927) (← links)
- Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management (Q38254290) (← links)
- Mechanisms of Antifungal Drug Resistance (Q38266675) (← links)
- Mechanisms of echinocandin antifungal drug resistance (Q38550402) (← links)
- Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China (Q38610744) (← links)
- Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients (Q38681635) (← links)
- Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials. (Q38811035) (← links)
- Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality. (Q38919690) (← links)
- Echinocandin Resistance in Candida Species: a Review of Recent Developments (Q38988521) (← links)
- In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris (Q39092177) (← links)
- The global problem of antifungal resistance: prevalence, mechanisms, and management (Q39092291) (← links)
- Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia (Q39230127) (← links)
- Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. (Q39977764) (← links)
- Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. (Q40040802) (← links)
- Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification (Q40045673) (← links)
- The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp. (Q40340923) (← links)
- In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates (Q40441738) (← links)
- Identification of Genes in Candida glabrata Conferring Altered Responses to Caspofungin, a Cell Wall Synthesis Inhibitor. (Q40602821) (← links)
- Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance (Q40738359) (← links)
- Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei (Q41075366) (← links)
- In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection (Q41079741) (← links)
- Antifungal resistance: current trends and future strategies to combat (Q41632930) (← links)
- Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates (Q41907460) (← links)
- Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria (Q41908678) (← links)
- Evaluation of caspofungin susceptibility testing by the new Vitek 2 AST-YS06 yeast card using a unique collection of FKS wild-type and hot spot mutant isolates, including the five most common candida species (Q42529877) (← links)
- Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria (Q43125888) (← links)
- EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole (Q44013179) (← links)
- Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata (Q47410811) (← links)
- Candida glabrata Biofilms: How Far Have We Come? (Q48163274) (← links)
- Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata (Q49936044) (← links)
- Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates. (Q50134184) (← links)
- Epidemiology of echinocandin resistance in (Q54156897) (← links)
- Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. (Q54957028) (← links)
- Portrait of Matrix Gene Expression in Candida glabrata Biofilms with Stress Induced by Different Drugs. (Q55516936) (← links)
- Invasive candidiasis (Q56040929) (← links)
- Spontaneous mutational frequency and mutation rates vary by echinocandin agent against (Q58100719) (← links)
- Significantly Improved Pharmacokinetics Enhances Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis (Q58701121) (← links)